Posted by David Stone on Jun 17th, 2017
Regulators from the U.S. Food and Drug Administration approved competition for the emergency allergy medicine EpiPen that put Mylan into the spotlight for pharmaceutical greed.
This week the FDA approved a product from Adamis Pharmaceuticals...
More of this article »